KaydedilenlerDerginizi ekleyin

Dergiler / Interdisciplinary Medical Journal / 2026 / Volume: 17 Issue: 57

Obstetric and neonatal outcomes in pregnant women with fibromyalgia syndrome: A retrospective case-control study

Gülsemin Ertürk Çelik(Gençlik ve Spor Bakanlığı)0000-0002-5440-8621
Sayfa
—
Yayın Tarihi
2026-04-16
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Pregnant women with FMS should be considered a high-risk group and managed with a multidisciplinary approach.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: This study aims to evaluate obstetric and neonatal outcomes in pregnant women diagnosed with fibromyalgia syndrome (FMS) and to investigate the relationship between disease severity and complications.
📊
Temel Bulgular & Veri:Methods: This retrospective case-control study was conducted between August 2018 and August 2019.
💡
Sonuç & Katkı:Pregnant women with FMS should be considered a high-risk group and managed with a multidisciplinary approach.
🔬Tür:Research Article
📍Kapsam:2018 Verileri
⚙️Değişkenler:Fibromyalgia syndrome · pregnancy · preterm birth

Abstract

Objective: This study aims to evaluate obstetric and neonatal outcomes in pregnant women diagnosed with fibromyalgia syndrome (FMS) and to investigate the relationship between disease severity and complications. Methods: This retrospective case-control study was conducted between August 2018 and August 2019. Sixty pregnant women diagnosed with FMS according to the 2016 ACR criteria were compared with 71 healthy pregnant women. FMS severity was assessed using the Widespread Pain Index (WPI) and Symptom Severity Scale (SSS). Obstetric complications, mode of delivery, and neonatal outcomes were recorded. Results: The mean age of pregnant women with FMS was significantly higher (30.8±4.6 vs 27.9±5.1 years, p=0.002). The preterm birth rate was 26.7% in the FMS group and 7.0% in the control group (p<0.001). Premature rupture of membranes was more frequent in the FMS group (18.3% vs 5.6%, p=0.003). Birth weight was significantly lower in the FMS group (2,880±410 vs 3,210±390 g, p<0.001). The rate of Apgar 1 <7 was 66.7% in the FMS group and 4.2% in the control group (p<0.001). Neonatal intensive care unit (NICU) admission rate was higher in the FMS group (21.7% vs 4.2%, p=0.002). Complication rates increased as disease severity increased (p<0.05). Conclusion: FMS is associated with serious obstetric and neonatal complications during pregnancy. Risks increase in parallel with disease severity. Pregnant women with FMS should be considered a high-risk group and managed with a multidisciplinary approach.

🔖

Bu Makaleye Atıf Yap

Çelik, G. E. (2026). Obstetric and neonatal outcomes in pregnant women with fibromyalgia syndrome: A retrospective case-control study. Interdisciplinary Medical Journal, Volume: 17 Issue: 57. https://doi.org/10.17944/interdiscip.1819793

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (26)

  1. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-610. https://doi.org/10.1002/acr.20140
  2. Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356. https://doi.org/10.1007/s11916-013-0356-5
  3. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-1555. https://doi.org/10.1001/jama.2014.3266
  4. Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022. https://doi.org/10.1038/nrdp.2015.22
  5. Ostensen M, Rugelsjøen A, Wigers SH. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol. 1997;26(5):355-360. https://doi.org/10.3109/03009749709065698
  6. Buskila D, Neumann L, Alhoashle A, Abu-Shakra M. Fibromyalgia in men. Semin Arthritis Rheum. 2000 Aug;30(1):47-51. https://doi.org/10.1053/sarh.2000.8363
  7. Zioni T, Buskila D, Aricha-Tamir B, Wiznitzer A, Sheiner E. Pregnancy outcome in patients with fibromyalgia syndrome. J Matern Fetal Neonatal Med. 2011;24(11):1325-1328. https://doi.org/10.3109/14767058.2010.551152
  8. Chakrabarty S, Zoorob R. Fibromyalgia. Am Fam Physician. 2007;76(2):247-254.
  9. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319-329. https://doi.org/10.1016/j.semarthrit.2016.08.012
  10. Ablin JN, Buskila D, Clauw DJ. Biomarkers in fibromyalgia. Curr Pain Headache Rep. 2009;13(5):343-349. https://doi.org/10.1007/s11916-009-0056-3
  11. Goldenberg DL. Diagnosis and differential diagnosis of fibromyalgia. Am J Med. 2009;122(12 Suppl):S14-21. https://doi.org/10.1016/j.amjmed.2009.09.007
  12. Buskila D, Sarzi-Puttini P. Fibromyalgia and pregnancy. Best Pract Res Clin Rheumatol. 2011;25(2):257-264. https://doi.org/10.1016/j.berh.2011.03.002
  13. Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients: a systematic review and meta-analysis. Rheumatol Int. 2017;37(9):1527-1539. https://doi.org/10.1007/s00296-017-3725-2
  14. Magtanong GG, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Maternal and neonatal outcomes among pregnant women with fibromyalgia: a population-based study of 12 million births. J Matern Fetal Neonatal Med. 2019;32(3):404-410. https://doi.org/10.1080/14767058.2017.1381684
  15. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37(11):1583-1592. https://doi.org/10.1002/art.1780371105
  16. Martinez-Lavin M. Biology and therapy of fibromyalgia: stress, the stress response system, and fibromyalgia. Arthritis Res Ther. 2007;9(4):216. https://doi.org/10.1186/ar2146
  17. Arnold LM, Clauw DJ, McCarberg BH; FibroCollaborative. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc. 2011;86(5):457-464. https://doi.org/10.4065/mcp.2010.0738
  18. Gentile S, Fusco ML. Managing fibromyalgia syndrome in pregnancy no bridges between USA and EU. Arch Womens Ment Health. 2019 Dec;22(6):711-721. https://doi.org/10.1007/s00737-018-0933-z
  19. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007;8:27. https://doi.org/10.1186/1471-2474-8-27
  20. Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015;67(2):568-575. https://doi.org/10.1002/art.38905
  21. Clauw DJ, Hassett AL. The role of centralised pain in osteoarthritis. Clin Exp Rheumatol. 2017;35 Suppl 107(5):79-84.
  22. Kennedy M, Felson DT. A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum. 1996;39(4):682-685. https://doi.org/10.1002/art.1780390422
  23. Findeisen K, Guymer E, Littlejohn G. Neuroinflammatory and Immunological Aspects of Fibromyalgia. Brain Sci. 2025 Feb 17;15(2):206. https://doi.org/10.3390/brainsci15020206
  24. Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448-453. https://doi.org/10.1016/j.semarthrit.2008.12.003
  25. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113-1122. https://doi.org/10.3899/jrheum.100594
  26. Ketenci S, Uzuner B, Durmuş D, et al. Frequency of idiopathic intracranial hypertension with ultrasound in patients with fibromyalgia: Relation with function, central sensitization, and neuropathic pain. Arthritis Care Res (Hoboken). 2010;62(5):600-610. https://doi.org/10.1002/acr.20140